ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000225218.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.030647022	Resistant
ENSG00000225218.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.032820943	Sensitive